For instance, studies in NSCLC patients treated with concurrent chemoradiotherapy (CRT) revealed that PD-L1 expression < 1% on tumor cells was related to improved overall survival (OS), and also patients with low CD8+ TIL density exhibited better OS [34]. Here, CD274 is linked to non-small cell lung carcinoma.